These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33374917)

  • 1. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
    Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
    Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
    Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
    Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANXA2 expression in African American triple-negative breast cancer patients.
    Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
    Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.
    Zhang Y; Bi J; Zhu H; Shi M; Zeng X
    Biosci Biotechnol Biochem; 2018 Oct; 82(10):1733-1741. PubMed ID: 29912633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation cycling of Annexin A2 Tyr23 is critical for calcium-regulated exocytosis in neuroendocrine cells.
    Gabel M; Delavoie F; Royer C; Tahouly T; Gasman S; Bader MF; Vitale N; Chasserot-Golaz S
    Biochim Biophys Acta Mol Cell Res; 2019 Jul; 1866(7):1207-1217. PubMed ID: 30610889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
    Gibbs LD; Vishwanatha JK
    Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
    Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression.
    Abdelraouf EM; Hussein RRS; Shaaban AH; El-Sherief HAM; Embaby AS; Abd El-Aleem SA
    Life Sci; 2022 Nov; 308():120967. PubMed ID: 36116530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells.
    Wang YQ; Zhang F; Tian R; Ji W; Zhou Y; Sun XM; Liu Y; Wang ZY; Niu RF
    Cancer Biol Med; 2012 Dec; 9(4):248-53. PubMed ID: 23691485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth.
    Sharma MC; Jain D
    Exp Mol Pathol; 2020 Oct; 116():104523. PubMed ID: 32866522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANXA2
    Xing X; Yuan H; Sun Y; Ke K; Dong X; Chen H; Liu X; Zhao B; Huang A
    J Proteomics; 2019 May; 200():111-122. PubMed ID: 30951906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
    Liu Z; Ling Q; Wang J; Xie H; Xu X; Zheng S
    Oncol Lett; 2013 Jul; 6(1):125-129. PubMed ID: 23946789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
    Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
    Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.